Watch Corporate Video
  • REACHing Every
    Needy Patient Globally
  • New Offerings
    Renewed Hope
  • Defining Possibilities
    Redefining Science
  • Rich Legacy
    Enriching Life

The leading edge of Hetero Group, Hetero Biopharma, is steadily establishing itself as a path breaking Biosimilar developer. As a strong R&D driven company offering some of the blockbuster Biosimilar Drugs, we at Hetero Biopharma are bringing about a paradigm shift in the way patients suffering from various chronic conditions are treated.

Read more >>>
State-of-the-art Manufacturing Facility
State-of-the-art R&D Facility
State-of-the-art R&D Facility
News

With leadership in chemical therapeutics,
Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies.

Genesis and Onwards

supportImage

2009

icon Conceptualized with the identification of Key Biosimilars

supportImage

2011

icon Completion of state-of-the-art R&D and Biologics manufacturing facility

supportImage

2014

icon Launch of Darbepoetin Alfa - First Biosimilar product of Hetero Biopharma

icon 2nd Company in the world to launch Biosimilar Darbepoetin

supportImage

2015

icon Launch of Rituximab Injection - 2nd Biosimilar and 1st MAB of Hetero Biopharma

icon Expansion of the Biosimilar facility to cater the demands of Global markets

supportImage

2016

icon Launch of Bevacizumab Injection - our 3rd Biosimilar product

icon GMP accreditation by PIC/s member country

icon Entry in to global markets

supportImage

2017

icon Launch of Adalimumab Injection – our 4th Biosimilar product

icon Expansion of the new manufacturing block completed

supportImage

2018

icon Clinical evaluation of anti HER 2 mAb in progress

icon Progress in filing of biosimilars in regulated markets

supportImage

2019

icon 1st company to launch Adalimumab autoinjector pen in India for better patient compliance

icon 1st company in Africa to market Biosimilars with a dedicated team with a mission of REACHing every needy patient

Our Core Competencies

We are constantly evolving and expanding our competencies, relentlessly and rapidly.

Read more >>>

Our Biosimilars

We strive to make complex Bio therapeutics available and more accessible to patients across the globe.

Read more >>>

Our Global Presence

Hetero Biopharma Insignia

The Hetero Biopharma Insignia is an apt interplay of a DNA and an hourglass. Together, they represent 'life' and 'time' thereby signifying Hetero's foray into modern biopharmaceuticals by not just offering high quality human biotechnology products but also focussing on their early commercialisation.

The colours Orange and Deep Yellow are obvious representation of the 'daybreak' and signify hope and life. The Grey colour signifies our intent to apply knowledge and expertise for better outcomes.